Asahi Kasei, a global provider of healthcare and pharmaceutical solutions, announced that Nefecon (marketed in the United States as TARPEYO® (budesonide) delayed release capsules), has been included ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback